AAWHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Ascend Wellness Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.39−0.00 (-0.73%)
Close on Oct 19, 2026
- Market cap
- $79.60M
- P/E (TTM)
- –
- Dividend yield
- –
Ascend Wellness Holdings, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Retail revenue | $92.73M | $83.13M | $84.97M | $83.78M | $86.46M | $84.35M | $90.36M | $93.60M | $93.08M | $95.21M | $97.31M | $101.26M | 73.5% | +7.2% |
| Third-party wholesale revenue | $33.39M | $33.81M | $35.58M | $40.95M | $40.85M | $43.65M | $45.65M | $48.05M | $48.46M | $47.21M | – | – | 26.5% | -18.2% |
| Wholesale revenue | – | – | – | – | – | – | – | $77.89M | $79.59M | $78.95M | $75.80M | $68.67M | – | – |
By region
From the segment and revenue-disaggregation notes of Ascend Wellness's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.